Boston Partners Sotera Health CO Transaction History

Boston Partners

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$14.04 - $18.98 $24.1 Million - $32.5 Million	-1,713,956 Reduced 56.89%	1,298,879 $24.5 Million
Q1 2023 May 09, 2023	SELL	$8.33 - $18.68 $351,684 - $788,650	-42,219 Reduced 1.38%	3,012,835 $54 Million
Q4 2022 Feb 07, 2023	SELL	$5.95 - $9.17 $323,019 - $497,830	-54,289 Reduced 1.75%	3,055,054 $25.4 Million
Q3 2022 Nov 09, 2022	BUY	$6.82 - $20.31 $15 Million - $44.8 Million	2,203,400 Added 243.22%	3,109,343 $21 Million
Q2 2022 Aug 10, 2022	BUY	$18.92 - $23.86 $141,710 - $178,711	7,490 Added 0.83%	905,943 $17.7 Million
Q1 2022 May 10, 2022	SELL	$18.37 - $23.27 $596,694 - $755,856	-32,482 Reduced 3.49%	898,453 $19.5 Million
Q4 2021 Feb 04, 2022	SELL	$20.73 - $27.28 $579,631 - $762,776	-27,961 Reduced 2.92%	930,935 $21.9 Million
Q3 2021 Nov 05, 2021	BUY	$22.25 - $26.52 $5.15 Million - $6.14 Million	231,540 Added 31.83%	958,896 $25.1 Million
Q2 2021 Aug 12, 2021	BUY	$21.6 - $26.29 $3.03 Million - $3.69 Million	140,478 Added 23.94%	727,356 $17.6 Million
Q1 2021 May 10, 2021	BUY	$24.03 - $28.98 $5.03 Million - $6.06 Million	209,199 Added 55.39%	586,878 $14.6 Million
Q4 2020 Feb 10, 2021	BUY	$25.1 - $28.0 $9.11 Million - $10.2 Million	362,795 Added 2437.48%	377,679 $10.4 Million
Q4 2020 Feb 04, 2021	BUY	$25.1 - $28.0 $373,588 - $416,752	14,884 New	14,884 $409,000

214

203M

34.2K

33.1K

Ticker SHC
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 282,902,016
Market Cap $4.72B
Description
Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medica...

Get notified when there are updates to the investment portfolio of Boston Partners, based on Form 13F filings with the SEC.

Stay updated on Boston Partners with notifications on news.